High initial technical success rates for superficial femoral artery revascularization are possible using multiple modalities. For these interventions to pose a serious challenge to open surgical bypass, improved primary patency in mid- and long-term follow-up must be achieved. In several smaller studies, covered stenting of the superficial femoral artery has shown superior patency at 2 years after intervention. The ongoing VIBRANT trial randomizes patients to superficial femoral artery intervention with either bare nitinol stents or Viabahn covered stents. The 3-year outcomes data from this trial will better define the role of percutaneous intervention for complex superficial femoral artery disease.
1. Dawson DL, Cutler BS, Meissner MH, Strandness DE, Jr.Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation98:678-686, 1998.
2.
2. Money SR, Herd JA, Isaacsohn JL, et al. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease. J Vasc Surg27:267-274; discussion 274-5, 1998.
3.
3. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA274(12):975-980, 1995.
5. Laird J, Jaff MR, Biamino G, et al. Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registry. J Vasc Interv Radiol16:1067-1073, 2005.
6.
6. Zeller T, Rastan A, Schwarzwalder U, et al. Percutaneous peripheral atherectomy of femoropopliteal stenoses using a new-generation device: six-month results from a single-center experience. J Endovasc Ther11:676-685, 2004.
7.
7. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol45:312-315, 2005.
8.
8. Mewissen MW. Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results. Tech Vasc Interv Radiol7:2-5, 2004.
9.
9. Duda SH, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol16:331-338, 2005.
10.
10. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation2002; 106:1505-1509.
11.
11. Saxon RR, Coffman JM, Gooding JM, et al. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol14:303-311, 2003.
12.
12. Jahnke T, Andresen R, Muller-Hulsbeck S, et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. J Vasc Interv Radiol14(1):41-51, 2003.
